✦ LIBER ✦

646 DOES ADJUVANT CHEMOTHERAPY TYPE DIFFER FOR UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA SURVIVAL?

✍ Scribed by Koni, Artan; Akdogan, Bulent; Kiziloz, Halil; Donmez, Irfan; Bilen, Cenk Yucel; Ozen, Haluk

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognosis factors for survival in the tr

✍ S.C. Park; Y.J. Kim; H.J. Ahn 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Adjuvant systemic chemotherapy in the tr

✍ Cheol Kwak; Sang Eun Lee; In Gab Jeong; Ja Hyeon Ku 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Expression of survivin does not predict

✍ Nakanishi, Kuniaki; Tominaga, Susumu; Hiroi, Sadayuki; Kawai, Toshiaki; Aida, Sh 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 130 KB

Factors Affecting the Survival of Patien

✍ Suleyman Ataus; Bulent Onal; Burcin Tunc; Ahmet Erozenci; Arman Cekmen; Ali Riza 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 152 KB

Adjuvant methotrexate, vinblastine, adri

✍ Norihito Soga; Kiminobu Arima; Yoshiki Sugimura 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Time to define an international standard

✍ Alison J. Birtle; Rebecca Lewis; Mark Johnson; Emma Hall; On Behalf of the POUT 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB